TW200745121A - Chemical compound - Google Patents

Chemical compound

Info

Publication number: TW200745121A
Authority: TW; Taiwan
Prior art keywords: chemical compound; methyl; same; present; relates
Prior art date: 2005-09-30

Application number

TW095135886A

Other languages

English (en)

Inventor

Frank Hossner

Original Assignee

Sb Pharmco Inc

Neurocrine Biosciences Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-09-30

Filing date

2006-09-28

Publication date

2007-12-16

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35395069&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW200745121(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-09-28 Application filed by Sb Pharmco Inc, Neurocrine Biosciences Inc filed Critical Sb Pharmco Inc

2007-12-16 Publication of TW200745121A publication Critical patent/TW200745121A/zh

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Addiction (AREA)
Child & Adolescent Psychology (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Hospice & Palliative Care (AREA)
Anesthesiology (AREA)
Psychology (AREA)
Pain & Pain Management (AREA)
Nutrition Science (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

TW095135886A 2005-09-30 2006-09-28 Chemical compound TW200745121A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0519957.5A GB0519957D0 (en)	2005-09-30	2005-09-30	Chemical compound
PCT/US2005/037576 WO2006044958A1 (en)	2004-10-19	2005-10-19	Pyrazolo [1,5-alpha] pyrimidinyl derivatives useful as corticotropin-releasing factor (crf) receptor antagonists

Publications (1)

Publication Number	Publication Date
TW200745121A true TW200745121A (en)	2007-12-16

Family

ID=35395069

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
TW094136095A TW200626599A (en)	2004-10-19	2005-10-17	CRF receptor antagonists and methods relating thereto
TW095135886A TW200745121A (en)	2005-09-30	2006-09-28	Chemical compound

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
TW094136095A TW200626599A (en)	2004-10-19	2005-10-17	CRF receptor antagonists and methods relating thereto

Country Status (21)

Country	Link
US (1)	US7879862B2 (zh)
EP (2)	EP1802627B1 (zh)
JP (2)	JP4901744B2 (zh)
KR (2)	KR20070088621A (zh)
CN (1)	CN101273043B (zh)
AR (2)	AR051461A1 (zh)
AU (2)	AU2005295353B2 (zh)
BR (1)	BRPI0616767A2 (zh)
CA (2)	CA2584567C (zh)
CR (1)	CR9918A (zh)
EA (1)	EA200801000A1 (zh)
GB (1)	GB0519957D0 (zh)
IL (1)	IL190225A0 (zh)
MA (1)	MA29850B1 (zh)
NO (2)	NO20072541L (zh)
NZ (1)	NZ554082A (zh)
PE (2)	PE20060586A1 (zh)
RU (1)	RU2007118683A (zh)
TW (2)	TW200626599A (zh)
UA (1)	UA92756C2 (zh)
WO (2)	WO2006044958A1 (zh)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7196078B2 (en)	2002-09-04	2007-03-27	Schering Corpoartion	Trisubstituted and tetrasubstituted pyrazolopyrimidines as cyclin dependent kinase inhibitors
RU2394035C2 (ru) *	2003-12-22	2010-07-10	Эс Би ФАРМКО ПУЭРТО РИКО ИНК.	Антагонисты crf-рецепторов и способы, относящиеся к ним
GB0519957D0 (en) *	2005-09-30	2005-11-09	Sb Pharmco Inc	Chemical compound
US7579360B2 (en)	2005-06-09	2009-08-25	Bristol-Myers Squibb Company	Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors
US7572807B2 (en)	2005-06-09	2009-08-11	Bristol-Myers Squibb Company	Heteroaryl 11-beta-hydroxysteroid dehydrogenase type I inhibitors
US8088779B2 (en) *	2005-09-30	2012-01-03	Smithkline Beecham (Cork) Limited	Pyrazolo [1,5-alpha] pyrimidinyl derivatives useful as corticotropin-releasing factor (CRF) receptor antagonists
GB0525068D0 (en)	2005-12-08	2006-01-18	Novartis Ag	Organic compounds
US8119658B2 (en)	2007-10-01	2012-02-21	Bristol-Myers Squibb Company	Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors
NZ586662A (en)	2007-12-19	2012-08-31	Vertex Pharma	PYRAZOLO[1,5-a]PYRIMIDINES USEFUL AS JANUS KINASE 2 INHIBITORS
NZ588376A (en)	2008-04-15	2011-06-30	Eisai R&D Man Co Ltd	3-phenylpyrazolo[5,1-b]thiazole compound having antagonism against corticotropin-releasing factor (CRF) receptor
US8349852B2 (en)	2009-01-13	2013-01-08	Novartis Ag	Quinazolinone derivatives useful as vanilloid antagonists
AR078521A1 (es) *	2009-10-08	2011-11-16	Eisai R&D Man Co Ltd	Compuesto pirazolotiazol
WO2011043387A1 (ja) *	2009-10-08	2011-04-14	エーザイ・アール・アンド・ディー・マネジメント株式会社	ピラゾロオキサゾール化合物
CN102762572A (zh)	2010-02-01	2012-10-31	诺瓦提斯公司	作为CRF-1受体拮抗剂的吡唑并[5,1b]*唑衍生物
WO2011092293A2 (en)	2010-02-01	2011-08-04	Novartis Ag	Cyclohexyl amide derivatives as crf receptor antagonists
CN102753527B (zh) *	2010-02-02	2014-12-24	诺华股份有限公司	用作crf受体拮抗剂的环己基酰胺衍生物
UY34094A (es)	2011-05-27	2013-01-03	Novartis Ag	Derivados de la piperidina 3-espirocíclica como agonistas de receptores de la ghrelina
WO2013074641A1 (en)	2011-11-16	2013-05-23	Array Biopharma Inc.	Piperidinyl- substituted cyclic ureas as gpr119 modulators
US20150094310A1 (en) *	2012-04-23	2015-04-02	Holsboermaschmeyer Neurochemie Gmbh	Crhr1 antagonists for use in the treatment of patients having crh overactivity
EA201491990A1 (ru)	2012-05-03	2015-02-27	Новартис Аг	L-малатная соль 2,7-диазаспиро[4.5]дец-7-иловых производных и их кристаллические формы в качестве агонистов грелиновых рецепторов
GB201210686D0 (en)	2012-06-15	2012-08-01	Holsboermaschmeyer Neurochemie Gmbh	V1B receptor antagonist for use in the treatment of patients having an elevated AVP level and/or an elevated copeptin level
GB201310782D0 (en)	2013-06-17	2013-07-31	Max Planck Innovation Gmbh	Method for predicting a treatment response to a CRHR1 antagonist and/or V1B antagonist in a patient with depressive and/or anxiety symptoms
FI3096756T3 (fi)	2014-01-21	2024-08-14	Neurocrine Biosciences Inc	Crf1-reseptorin antagonisteja synnynnäisen lisämunuaisen liikakasvun hoitoon
BR112016016798B1 (pt) *	2014-01-22	2022-06-28	Curovir Ab	Composto, composição farmacêutica, e, uso de um composto
EP3582783B1 (en)	2017-02-17	2023-06-07	Trevena, Inc.	7-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same
WO2018165520A1 (en)	2017-03-10	2018-09-13	Vps-3, Inc.	Metalloenzyme inhibitor compounds
TW202446384A (zh)	2018-12-07	2024-12-01	美商紐羅克里生物科學有限公司	用於治療先天性腎上腺增生之crf1受體拮抗劑、醫藥配方及其固體形式
WO2021062246A1 (en)	2019-09-27	2021-04-01	Neurocrine Biosciences, Inc.	Crf receptor antagonists and methods of use
BR112022011917A2 (pt)	2019-12-20	2022-09-06	Tenaya Therapeutics Inc	Fluoroalquil-oxadiazois e seus usos
EP4236939A4 (en) *	2020-10-27	2024-08-07	Trevena, Inc.	Crystalline and amorphous forms of a delta-opioid modulator
MX2023012875A (es)	2021-05-04	2024-01-12	Tenaya Therapeutics Inc	Inhibidores 2-fluoro alquil-l,3,4-oxadiazol-5-il-tiazol de hdac6 para su uso en el tratamiento de enfermedades metabólicas y hfpef.

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4605642A (en)	1984-02-23	1986-08-12	The Salk Institute For Biological Studies	CRF antagonists
DE69523864T2 (de)	1994-06-21	2002-06-13	Otsuka Pharmaceutical Factory, Inc.	PYRAZOLO[1,5-a] PYRIMIDIN-DERIVATE
US6664261B2 (en)	1996-02-07	2003-12-16	Neurocrine Biosciences, Inc.	Pyrazolopyrimidines as CRF receptor antagonists
ATE336495T1 (de)	1996-02-07	2006-09-15	Neurocrine Biosciences Inc	Pyrazolopyrimidine als crf rezeptor-antagonisten
US6313124B1 (en)	1997-07-23	2001-11-06	Dupont Pharmaceuticals Company	Tetrazine bicyclic compounds
EA006626B1 (ru)	1996-07-24	2006-02-24	Дюпон Фармасьютикалз Компани	Азолопиримидины, фармацевтическая композиция и способ лечения
JP4704521B2 (ja) *	1996-07-24	2011-06-15	ブリストル−マイヤーズスクイブファーマカンパニー	アゾロトリアジン類およびアゾロピリミジン類
US6060478A (en) *	1996-07-24	2000-05-09	Dupont Pharmaceuticals	Azolo triazines and pyrimidines
JPH10101672A (ja)	1996-08-06	1998-04-21	Otsuka Pharmaceut Factory Inc	アデノシン増強剤
JPH10101671A (ja)	1996-08-08	1998-04-21	Otsuka Pharmaceut Factory Inc	一酸化窒素合成酵素阻害剤
NZ333302A (en)	1996-08-28	2000-08-25	Pfizer	Substituted 6,5-hetero-bicyclic derivatives for the prevention or inhibition of a disorder that can be treated by antagonising corticotropin releasing factor
CA2614603C (en) *	1998-01-28	2011-08-16	Bristol-Myers Squibb Pharma Company	Azolo triazines and pyrimidines
JP2000038350A (ja)	1998-05-18	2000-02-08	Yoshitomi Pharmaceut Ind Ltd	糖尿病治療薬
AU2321000A (en)	1999-01-29	2000-08-18	Sumitomo Chemical Company, Limited	Fat accumulation inhibitory agents
WO2000059908A2 (en) *	1999-04-06	2000-10-12	Du Pont Pharmaceuticals Company	Pyrazolopyrimidines as crf antagonists
PL354675A1 (en)	1999-09-30	2004-02-09	Neurogen Corporation	Certain alkylene diamine-substituted pyrazolo[1,5,-a]-1,5-pyrimidines and pyrazolo[1,5-a]-1,3,5-triazines
CZ20021089A3 (cs) *	1999-09-30	2002-11-13	Neurogen Corporation	Aminosustituované pyrazolo[1,5-a]-1,5-pyrimidiny a pyrazolo[1,5-a]-1,3,5-triaziny
CO5271670A1 (es)	1999-10-29	2003-04-30	Pfizer Prod Inc	Antagonistas del factor de liberacion de corticitropina y composiciones relacionadas
AR033295A1 (es)	2001-04-30	2003-12-10	Glaxo Group Ltd	Compuestos biciclicos de pirimidina, proceso para su obtencion, uso de los mismos para la preparacion de una composicion farmaceutica y dicha composicion farmaceutica
US7462622B2 (en)	2001-06-12	2008-12-09	Glaxo Group Limited	Pyrrolo[2, 3-d] pyrimidine derivatives as corticotropin releasing factor antagonists
GB0117396D0 (en)	2001-07-17	2001-09-05	Glaxo Group Ltd	Chemical compounds
CA2487211C (en)	2002-06-04	2010-09-14	Neogenesis Pharmaceuticals, Inc.	Pyrazolo(1,5a) pyrimidine compounds as antiviral agents
ES2285409T3 (es)	2003-01-16	2007-11-16	Sb Pharmco Puerto Rico Inc	Derivados pirrol(2,3-b)piridina sustituidos con heteroarilo como antagonistas del receptor de crf.
US20070179161A1 (en)	2003-03-31	2007-08-02	Vernalis (Cambridge) Limited.	Pyrazolopyrimidine compounds and their use in medicine
GB0308208D0 (en)	2003-04-09	2003-05-14	Glaxo Group Ltd	Chemical compounds
US20070021429A1 (en)	2003-04-09	2007-01-25	Yves St-Denis	Condensed n-heterocyclic compounds and their use as crf receptor antagonists
WO2005063756A1 (en)	2003-12-22	2005-07-14	Sb Pharmco Puerto Rico Inc	Crf receptor antagonists and methods relating thereto
RU2394035C2 (ru)	2003-12-22	2010-07-10	Эс Би ФАРМКО ПУЭРТО РИКО ИНК.	Антагонисты crf-рецепторов и способы, относящиеся к ним
DE102004008807A1 (de)	2004-02-20	2005-09-08	Bayer Cropscience Ag	Pyrazolopyrimidine
ES2326827T3 (es)	2004-10-19	2009-10-20	Smithkline Beecham (Cork) Limited	Anatagonistas del receptor de crf y metodos relacionados.
GB0519957D0 (en) *	2005-09-30	2005-11-09	Sb Pharmco Inc	Chemical compound
US8088779B2 (en) *	2005-09-30	2012-01-03	Smithkline Beecham (Cork) Limited	Pyrazolo [1,5-alpha] pyrimidinyl derivatives useful as corticotropin-releasing factor (CRF) receptor antagonists

2005
- 2005-09-30 GB GBGB0519957.5A patent/GB0519957D0/en not_active Ceased
- 2005-10-17 PE PE2005001219A patent/PE20060586A1/es not_active Application Discontinuation
- 2005-10-17 TW TW094136095A patent/TW200626599A/zh unknown
- 2005-10-17 AR ARP050104337A patent/AR051461A1/es not_active Application Discontinuation
- 2005-10-19 US US11/576,957 patent/US7879862B2/en active Active
- 2005-10-19 CA CA2584567A patent/CA2584567C/en not_active Expired - Fee Related
- 2005-10-19 RU RU2007118683/04A patent/RU2007118683A/ru not_active Application Discontinuation
- 2005-10-19 JP JP2007537996A patent/JP4901744B2/ja not_active Expired - Lifetime
- 2005-10-19 WO PCT/US2005/037576 patent/WO2006044958A1/en not_active Ceased
- 2005-10-19 AU AU2005295353A patent/AU2005295353B2/en not_active Ceased
- 2005-10-19 KR KR1020077008794A patent/KR20070088621A/ko not_active Ceased
- 2005-10-19 NZ NZ554082A patent/NZ554082A/en not_active IP Right Cessation
- 2005-10-19 EP EP05818308A patent/EP1802627B1/en not_active Expired - Lifetime
2006
- 2006-09-28 EP EP06805979A patent/EP1934222B1/en active Active
- 2006-09-28 JP JP2008532687A patent/JP2009510004A/ja not_active Ceased
- 2006-09-28 TW TW095135886A patent/TW200745121A/zh unknown
- 2006-09-28 CA CA002624699A patent/CA2624699A1/en not_active Abandoned
- 2006-09-28 KR KR1020087007620A patent/KR20080063760A/ko not_active Withdrawn
- 2006-09-28 PE PE2006001185A patent/PE20070845A1/es not_active Application Discontinuation
- 2006-09-28 UA UAA200803939A patent/UA92756C2/ru unknown
- 2006-09-28 WO PCT/EP2006/009531 patent/WO2007039264A1/en not_active Ceased
- 2006-09-28 BR BRPI0616767-5A patent/BRPI0616767A2/pt not_active IP Right Cessation
- 2006-09-28 CN CN2006800355977A patent/CN101273043B/zh not_active Expired - Fee Related
- 2006-09-28 AR ARP060104269A patent/AR056104A1/es not_active Application Discontinuation
- 2006-09-28 AU AU2006298995A patent/AU2006298995B2/en not_active Ceased
- 2006-09-28 EA EA200801000A patent/EA200801000A1/ru unknown
2007
- 2007-05-16 NO NO20072541A patent/NO20072541L/no not_active Application Discontinuation
2008
- 2008-03-17 IL IL190225A patent/IL190225A0/en unknown
- 2008-04-04 MA MA30813A patent/MA29850B1/fr unknown
- 2008-04-23 NO NO20081941A patent/NO20081941L/no not_active Application Discontinuation
- 2008-04-23 CR CR9918A patent/CR9918A/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
GB0519957D0 (en)	2005-11-09
JP2008517067A (ja)	2008-05-22
NZ554082A (en)	2010-12-24
JP4901744B2 (ja)	2012-03-21
NO20072541L (no)	2007-06-25
IL190225A0 (en)	2009-09-22
CA2584567C (en)	2013-04-30
AU2006298995B2 (en)	2012-06-14
EP1802627B1 (en)	2012-08-29
KR20080063760A (ko)	2008-07-07
EP1934222A1 (en)	2008-06-25
CA2624699A1 (en)	2007-04-12
WO2007039264A1 (en)	2007-04-12
CR9918A (es)	2009-02-03
AU2005295353A1 (en)	2006-04-27
CN101273043B (zh)	2011-08-03
UA92756C2 (ru)	2010-12-10
CN101273043A (zh)	2008-09-24
AR056104A1 (es)	2007-09-19
RU2007118683A (ru)	2008-11-27
EA200801000A1 (ru)	2009-02-27
KR20070088621A (ko)	2007-08-29
AR051461A1 (es)	2007-01-17
JP2009510004A (ja)	2009-03-12
AU2006298995A1 (en)	2007-04-12
PE20060586A1 (es)	2006-09-20
MA29850B1 (fr)	2008-10-03
EP1934222B1 (en)	2012-07-25
AU2005295353B2 (en)	2012-01-12
CA2584567A1 (en)	2006-04-27
US7879862B2 (en)	2011-02-01
US20080194589A1 (en)	2008-08-14
NO20081941L (no)	2008-04-23
BRPI0616767A2 (pt)	2011-06-28
WO2006044958A1 (en)	2006-04-27
PE20070845A1 (es)	2007-08-25
TW200626599A (en)	2006-08-01
WO2006044958A8 (en)	2006-06-08
EP1802627A1 (en)	2007-07-04

Publication	Publication Date	Title
TW200745121A (en)	2007-12-16	Chemical compound
MXPA05012025A (es)	2006-02-03	Imidazo y tiazolopiridinas como inhibidores de cinasa jak3.
WO2007023382A3 (en)	2007-04-26	Pyrimidine amino pyrazole compounds, potent kinase inhibitors
WO2005002626A3 (en)	2005-05-26	Therapeutic phosphonate compounds
MX2011005937A (es)	2011-12-16	Compuestos organicos.
MX2007003108A (es)	2007-05-24	Compuestos imidazo-3-il-amina sustituidos y biciclicos.
WO2004112719A3 (en)	2005-04-07	Chemical compounds
ATE365740T1 (de)	2007-07-15	Substituierte pyrazolopyrimidine
EP1814885A4 (en)	2009-12-16	NOVEL HETEROCYCLIC BICYCLIC COMPOUNDS, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING SAME
WO2008020455A3 (en)	2008-04-17	Pyrrolo[2,1-c][1,4]benzodiazepine hybrids and a process for the preparation thereof
WO2007050587A3 (en)	2007-11-29	Therapeutic compositions and methods
TW200621716A (en)	2006-07-01	Novel compounds
WO2006138528A3 (en)	2007-03-15	Tricyclic opioid modulators
MX2008011576A (es)	2008-09-22	Compuestos de imidazo[2,1-b]tiazol sustituidos y su uso para la produccion de farmacos.
SI2185561T1 (sl)	2011-10-28	Derivati 1,2,3,4-tetrahidropirolo(1,2-alfa)pirazin-6-karboksamidov in 2,3,4,5-tetrahidropirolo(1,2-alfa)-diazepin-7-karboksamidov, njihova priprava in njihova terapevtska uporaba
SI1869038T1 (sl)	2009-12-31	Substituirane 5,6,7,8-tetrahidro-imidazo(1,2-a)piridin-2-ilaminske spojine in njihova uporaba za pripravo zdravil
WO2005103052A8 (en)	2006-04-13	Pyrazolo [1,5-a] pyrimidin-7-one compounds and uses thereof
WO2007030089A8 (en)	2007-05-31	Tricyclic delta- opioid modulators
IL180942A0 (en)	2007-07-04	Synthesis of 6,7-dihydro-5h-imidazo[1,2-a]imidazole-3-sulfonic acid amides
DK1742950T3 (da)	2009-03-16	Pyrazolo-[4,3-D]-pyrimidiner
WO2006044753A3 (en)	2006-08-17	Chemical compounds
SI1899350T1 (sl)	2010-09-30	Derivati pirazolo d azepina kot antagonisti histamina h
IL187441A0 (en)	2008-02-09	Derivatives of 6,7-dihydro-5h-imidazo[1,2-a] imidazole-3-sulfonic acid
WO2006074388A3 (en)	2006-08-31	TRICYCLIC δ-OPIOID MODULATORS
WO2003045940A3 (en)	2003-09-12	Benzazepine derivatives and their use as 5-ht ligands